Managers / Q3 2022
S. MUOIO & CO. LLC
CIK 0001138996 · 509 MADISON AVE, SUITE 406, NEW YORK, NY, 10022 · 212-297-2555
Summary
S. Muoio & Co. LLC reported $76M in U.S.-listed holdings across 62 positions for Q3 2022.
Its largest position, NXST, represents 6.2% of the portfolio.
Compared with Q2 2022, the fund opened 21 new positions and exited 26.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 83.5% · $63M
- Other · 10.9% · $8M
- PUBLIC · 2.5% · $2M
- REIT · 1.9% · $1M
- MLP · 1.2% · $932,000
Quarter-over-Quarter Changes full breakdown →
vs Q2 2022 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| CHEMOCENTRYX INC | NEW | +58.0K | 58.0K | +$3M | $3M |
| GLOBAL BLOOD THERAPEUTICS IN | NEW | +40.7K | 40.7K | +$3M | $3M |
| RESOLUTE FOREST PRODUCTS | NEW | +127.0K | 127.0K | +$3M | $3M |
| NIELSEN N.V. | NEW | +89.7K | 89.7K | +$2M | $2M |
| YUSDALLEGHANY CORP | NEW | +2.9K | 2.9K | +$2M | $2M |
| AVALARA INC | NEW | +22.5K | 22.5K | +$2M | $2M |
| ZENDESK INC | NEW | +21.0K | 21.0K | +$2M | $2M |
| 1LIFE HEALTHCARE INC | NEW | +80.0K | 80.0K | +$1M | $1M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q3 2022
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q3 2022 | $76M | 62 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $70M | 68 | Aug 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $85M | 85 | May 13, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $252M | 90 | Feb 10, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $130M | 107 | Nov 15, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $118M | 100 | Aug 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $93M | 81 | May 14, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $92M | 79 | Feb 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $88M | 72 | Nov 10, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $82M | 64 | Aug 10, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $77M | 63 | May 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $111M | 71 | Feb 12, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $95M | 75 | Nov 12, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $123M | 77 | Aug 2, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $109M | 66 | May 9, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $114M | 71 | Feb 7, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.